ID: ALA4204887

Max Phase: Preclinical

Molecular Formula: C10H12BNO7S

Molecular Weight: 301.08

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1cccc(CS(=O)(=O)C(=O)NCB(O)O)c1

Standard InChI:  InChI=1S/C10H12BNO7S/c13-9(14)8-3-1-2-7(4-8)5-20(18,19)10(15)12-6-11(16)17/h1-4,16-17H,5-6H2,(H,12,15)(H,13,14)

Standard InChI Key:  QHDNHPVOCKRDPE-UHFFFAOYSA-N

Associated Targets(non-human)

Beta-lactamase 1 50 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 301.08Molecular Weight (Monoisotopic): 301.0428AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. González-Bello C..  (2017)  Antibiotic adjuvants - A strategy to unlock bacterial resistance to antibiotics.,  27  (18): [PMID:28827113] [10.1016/j.bmcl.2017.08.027]

Source